Emversity Allied Health Sciences programs
ApplyApply for Allied Health Sciences programs by Emversity
Search Colleges, Exams, Schools & more
Interested in this College?
Get updates on Eligibility, Admission, Placements Fees Structure
Get updates on Eligibility, Admission, Placements Fees Structure
Updated on Apr 15 2025, 04:39 PM IST by Ashwini
Applications for Admissions are open.
Amrita Vishwa Vidyapeetham Allied & Life Science 2025
ApplyAdmissions Open for multiple allied and health sciences programs across 5 campuses | Ranked #7 in India by NIRF, NAAC A++ Accredited
JSS University Mysore 2025
ApplyNAAC A+ Accredited| Ranked #24 in University Category by NIRF | Applications open for multiple UG & PG Programs
NEET 1-to-1 Counseling Guidance
ApplyCollege Predictors Webinars One to One Counselling Regular Updates Medical Almanac
Dayananda Sagar University | Health Sciences Admissions 2025
Apply60+ Years of Education Legacy | UGC & AICTE Approved | NAAC A+ Grade | Scholarship Worth 6 Crores
NIMS University Paramedical Admissions 2025
ApplyAccredited by NAAC | NIRF Rank band 101-150 | Avail up to 100% Scholarships
Explore Vivek Group of Colleges, Bijnor Courses
Student Reviews for Vivek Group of Colleges, Bijnor
4/5(1 Reviews)
My awesome college and my struggling experience
Have a question related to Vivek Group of Colleges, Bijnor ?
Hey there,
Hope you are doing good.
Vivek Group Of college is located in Bijnor of Uttar Pradesh. There are many courses offered by college for students. The courses available are 28 in total. D.Pharma is one of the course offered by the college. The course is of 2-year duration. Fee structure is 56,000 as General fees. For admission process you need to fill the application through the official website. Then proceed by paying the registration and Print out of the registration form must be submitted.
If you want know more information regarding the course download brochure through this link:
https://www.careers360.com/colleges/vivek-group-of-colleges-bijnor/dpharma-course
Articles
Jun 14, 2025
Back to top